Intriguingly, some of these latter types of cancers are responsive to PD-1/PD-L1 blockade even when the tumours were defective in MHC-I expression suggesting immune cells other than cytotoxic T cells can play a role [59]. The gene discussed is PDCD1; the disease is neoplasm.